Helicobacter infection
Conditions
Interventions
Tailored treatment Group:Tailored treatment
Empirical Treatment Group:Quadruple regimen containing clarithromycin
Sponsors
Peking University Third Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Patients who visited the gastroenterology department of our hospital for gastroscopy 2. Patients requiring primary eradication therapy for H. pylori infection 3. Age 18-75 years old 4. Male or female
Exclusion criteria
Exclusion criteria: 1. Drugs that may affect the study results, such as PPI, H2 receptor antagonists, bismuth, antibiotics or traditional Chinese medicine with H. pylori inhibitory effect, were taken within 4 weeks before enrollment 2. Patients with malignant tumors of digestive tract 3. Patients with a history of gastric or esophageal surgery 4. Patients with severe underlying diseases 5. Patients who have previously eradicated Helicobacter pylori 6. Patients who are allergic to the drugs used in this study 7. Pregnant or breastfeeding women 8. Patients who are unwilling to participate or unable to cooperate with this study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Eradication rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Compliance; | — |
Countries
China
Contacts
Public ContactZhiqiang Song
Department of Gastroenterology, Peking University Third Hospital
Outcome results
None listed